Document 375O5wLQKdMkZeGrnkxXaweBD

To: Bruce Jarnot <jarnotb@api.org>; benzene-erp@listserve.api.org <benzene- erp@listserve.api.org>; benzene-srp@listserve.api.org <benzene-srp@listserve.api.org> From: Clayton, Ellen W <ellen.w.clayton@vanderbilt.edu> Cc: Bcc: Received Date: 2004-08-25 14:28:21 GMT Subject: Re: SRP & ERP.... Mid-year 2004 DP/ME Progress Report Bruce and fellow panel members, I am attaching a document that contains the bullet points I was asked for as well as residual concern about the commercialization issue. I am more than happy to get suggestions. Ellen --On Wednesday, August 04,20049:25 AM -0400 Bruce Jarnot <jarnotb@api.org> wrote: > > > Scientific & Ethics Review Panel (SRP & ERP) Members> > > Attached for your review is a copy of Dr. Iron's mid-year (July > 2004) DP/ME progress report. > Note that Figure 3 (pages 15-16) is currently missing from the > document, and will be added later. > A copy of the report will also be available on the SHS web site. > > > > Best Regards - Bruce. > > ***** > Bruce M. Jarnot, Ph.D., DABT > American Petroleum Institute > Regulatory and Scientific Affairs > 1220 L Street, NW (Suite 900) > Washington, DC 20005-4070 > phone: (202) 682-8473 fax: -8031 > email: jarnotb@api.org Ellen Wright Clayton, M.D., J.D. Vanderbilt University Rosalind E. Franklin Professor and Director, Center for Genetics and Health Policy Professor of Pediatrics Professor of Law 507A Light Hall Nashville, TN 37232-0165 phone: 615-322-1186 fax: 615-322-4548 Email: ellen.w.clayton@Vanderbilt.Edu SHELL-MCCLURG-056613 Attachments: Points for the Shanghai study. doc SHELL-MCCLURG-056614